InvestorsHub Logo
Followers 1172
Posts 169928
Boards Moderated 4
Alias Born 12/20/2003

Re: 02opida post# 616457

Sunday, 04/07/2024 7:58:11 AM

Sunday, April 07, 2024 7:58:11 AM

Post# of 618854
AMRN - New REDUCE-IT(TM) Analyses Show VASCEPA(TM)/VAZKEPA(TM) (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

History.htm

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.